The treatment of vitiligo is still a challenge. Among various therapeutic modalities, phototherapy with UVB narrowband (UVB-NB) is presently considered a treatment of choice for this skin disease. The exact skin cancer risk deriving from UVB-NB is a serious concern to be determined. We report a case of keratoacanthoma developed in the vitiligo area during a prolonged course of UVB-NB therapy.
|Number of pages||3|
|Journal||Photodermatology Photoimmunology and Photomedicine|
|Publication status||Published - Aug 2006|
- Photocarcinogenic risk
- UVB-narrowband therapy
ASJC Scopus subject areas